Neuropsyquiatric Evolution After Introduction of Raltegravir QD in Substitution of Dolutegravir: NEAR QD Study
NCT03732625
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
50
Enrollment
OTHER
Sponsor class
Conditions
HIV Infections
Interventions
DRUG:
Raltegravir
Sponsor
Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud
Collaborators
[object Object]